The intrahepatic tumor number, macrovascular invasion, Barcelona Clinic Liver Cancer (BCLC) stage, NLR, CRP level, and prior ATB were identified as significant predictors associated with the PFS based on mRECIST. This evidence concerns the gene CRP and liver cancer.